TABLE 1.
Controls | Cases | ||||||||
A | B | O | Total controls | A | B | O | Total cases | Total samples | |
Complete study | 108 | 52 | 116 | 276 | 126 | 48 | 116 | 290 | 566 |
Sub-study randomization | 30 | 30 | 30 | 90 | 30 | 30 | 30 | 90 | 180 |
Tested samples | 30 | 30 | 29 | 89 | 29 | 22 | 30 | 81 | 170 |
Actual sub studya | 28 (−2) | 28 (−2) | 26 (−3) | 82 | 31 (29 + 2) | 24 (22 + 2) | 33 (30 + 3) | 88b | 170 |
aSeven controls were reclassified as cases because of anti-SARS-CoV-2 seropositivity.bAmong cases, 75 were symptomatic and 13 were asymptomatic.